{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:55:21Z","timestamp":1789052121421,"version":"build-2803163510"},"reference-count":129,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Obesity has become increasingly prevalent, impacting up to 41 percent of women in the United States between 2021 and 2023, leading to a rise in short- and long-term adverse health events. With regard to reproductive health, obesity is associated with menstrual irregularities, poorer reproductive and obstetric outcomes, and an increased risk of endometrial cancer. Obesity can lead to hyperandrogenism and anovulation, which is consistent with polycystic ovarian syndrome (PCOS). The prevalence of obesity is higher in women with PCOS compared to the general population. Although PCOS increases the risk of obesity, not all women with PCOS are obese, and not all women with obesity develop PCOS. However, individuals with both PCOS and obesity often present with a more extreme phenotype, with increased risk of chronic anovulation, glucose intolerance, dyslipidemia, metabolic syndrome, vitamin D deficiency, and decreased fertility. Therefore, weight loss is the backbone of patient management in women with obesity and PCOS, and is associated with improvement in cardiovascular risk, as well as improvement in menstrual cycles, ovulation, and pregnancy rate. Lifestyle modifications are often the first-line intervention, with data supporting low glycemic index diets, including ketogenic and DASH diets, along with vitamin D supplementation to improve hormonal imbalances, insulin sensitivity, and menstrual cycles in those who do not have normal vitamin D levels. Furthermore, with the recent widespread adoption of newer FDA-approved medications for weight loss, including GLP-1 (glucagon-like peptide) receptor agonists, new data are emerging regarding the impact of PCOS and longer-term cardiovascular risk. The treatment of PCOS requires a personalized approach, with consideration of a patient\u2019s reproductive goals, tolerance of risk, and acceptance of behavioral and financial commitments, as well as consideration of other medical comorbidities. This narrative review explores different weight loss treatment options, comparing lifestyle modifications (including diet, physical activity, mindfulness, stress management, and cognitive behavioral training), weight loss medications, and bariatric surgery and their respective impact on PCOS to assist clinicians in guiding their patients towards an effective, individualized intervention.<\/jats:p>","DOI":"10.3390\/jpm15110518","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:32:01Z","timestamp":1762191121000},"page":"518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3347","authenticated-orcid":false,"given":"Alexa C.","family":"Dzienny","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref_1","first-page":"21","article-title":"Impact of Obesity and Weight Management on Women with Polycystic Ovary Syndrome and Coexisting Obesity\u2014A Brief Narrative Review","volume":"15","author":"Ghafoor","year":"2023","journal-title":"Actual Gyn."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., and Arora, T. (2025). The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients, 17.","DOI":"10.3390\/nu17020310"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mahabamunuge, J., Sekula, N.M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H.J., Seifer, D.B., and AlAshqar, A. (2025). The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications\u2014A Narrative Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13030709"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","article-title":"Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: A network meta-analysis","volume":"18","author":"Zhao","year":"2021","journal-title":"Reprod. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil. Steril."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pal, L., and Seifer, D.B. (2022). Polycystic Ovary Syndrome: Current and Emerging Concepts, Springer International Publishing.","DOI":"10.1007\/978-3-030-92589-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: A systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155745","DOI":"10.1016\/j.metabol.2023.155745","article-title":"Bariatric Surgery in Women with Polycystic Ovary Syndrome","volume":"151","author":"Samarasinghe","year":"2024","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7570\/jomes24035","article-title":"Obesity and Polycystic Ovary Syndrome","volume":"33","author":"Kim","year":"2024","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","article-title":"Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome","volume":"23","author":"Das","year":"2008","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2024.08.243","article-title":"Anti-m\u00fcllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: A systematic review and meta-analysis","volume":"122","author":"Laven","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.fertnstert.2024.07.002","article-title":"Elevated antim\u00fcllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome","volume":"122","author":"Seifer","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rafiq, S., and Jeppesen, P.B. (2021). Vitamin D Deficiency Is Inversely Associated with Homeostatic Model Assessment of Insulin Resistance. Nutrients, 13.","DOI":"10.3390\/nu13124358"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fertnstert.2013.04.022","article-title":"Transforming growth factor-\u03b21 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation","volume":"100","author":"Tal","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jc.2015-2580","article-title":"Vitamin D Supplementation Decreases TGF-\u03b21 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial","volume":"100","author":"Irani","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The Emerging Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome","volume":"33","author":"Tal","year":"2015","journal-title":"Semin. Reprod. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1095\/biolreprod61.4.993","article-title":"Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells","volume":"61","author":"Spaczynski","year":"1999","journal-title":"Biol. Reprod."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1210\/jc.2010-0770","article-title":"Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability","volume":"95","author":"Sokalska","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/jc.2016-1858","article-title":"Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial","volume":"101","author":"Banaszewska","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/molehr\/gaq002","article-title":"Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells","volume":"16","author":"Wong","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","article-title":"Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review","volume":"13","author":"He","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut Microbial Diversity in Women with Polycystic Ovary Syndrome Correlates with Hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12916-023-02975-8","article-title":"Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"21","author":"Li","year":"2023","journal-title":"BMC Med."},{"key":"ref_30","first-page":"51","article-title":"Synbiotic Supplementation Improves Metabolic Factors and Obesity Values in Women with Polycystic Ovary Syndrome Independent of Affecting Apelin Levels: A Randomized Double-Blind Placebo\u2014Controlled Clinical Trial","volume":"15","author":"Darvishi","year":"2021","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_31","unstructured":"Emmerich, S.D., Fryar, C.D., Stierman, B., Bryan Stierman, M.D., and Ogden, C.L. (2024). Products\u2014Data Briefs\u2014Number 508, National Center for Health Statistics."},{"key":"ref_32","unstructured":"(2025, August 21). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-024-01339-y","article-title":"Medical therapy to treat obesity and optimize fertility in women of reproductive age: A narrative review","volume":"23","author":"Duah","year":"2025","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.fertnstert.2021.08.018","article-title":"Obesity and reproduction: A committee opinion","volume":"116","author":"Penzias","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM195207102470204","article-title":"The relation of obesity to menstrual disturbances","volume":"247","author":"Rogers","year":"1952","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e49217","DOI":"10.1371\/journal.pone.0049217","article-title":"High fat diet induced developmental defects in the mouse: Oocyte meiotic aneuploidy and fetal growth retardation\/brain defects","volume":"7","author":"Luzzo","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1210\/en.2010-0098","article-title":"Diet-induced obesity model: Abnormal oocytes and persistent growth abnormalities in the offspring","volume":"151","author":"Jungheim","year":"2010","journal-title":"Endocrinology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12958-025-01434-8","article-title":"Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes","volume":"23","author":"Moreira","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_39","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/01674829609025672","article-title":"A group program for obese, infertile women: Weight loss and improved psychological health","volume":"17","author":"Galletly","year":"1996","journal-title":"J. Psychosom. Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.fertnstert.2014.01.036","article-title":"A retrospective cohort study to evaluate the impact of meaningful weight loss on fertility outcomes in an overweight population with infertility","volume":"101","author":"Kort","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized Controlled Trial of Preconception Interventions in Infertile Women with Polycystic Ovary Syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa1505297","article-title":"Randomized Trial of a Lifestyle Program in Obese Infertile Women","volume":"374","author":"Mutsaerts","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2019.05.043","article-title":"The combined impact of maternal age and body mass index on cumulative live birth following in vitro fertilization","volume":"221","author":"Goldman","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/humrep\/dep101","article-title":"The effect of weight loss on anti-M\u00fcllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment","volume":"24","author":"Thomson","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.12891\/ceog3037.2016","article-title":"Effect of a low glycemic diet in patients with polycystic ovary syndrome and anovulation\u2014A randomized controlled trial","volume":"43","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3945\/ajcn.2010.29261","article-title":"Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome","volume":"92","author":"Marsh","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","article-title":"Dietary Composition in the Treatment of Polycystic Ovary Syndrome: A Systematic Review to Inform Evidence-Based Guidelines","volume":"113","author":"Moran","year":"2013","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","article-title":"Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome","volume":"105","author":"Shang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12958-025-01411-1","article-title":"Effects of ketogenic diets on polycystic ovary syndrome: A systematic review and meta-analysis","volume":"23","author":"Cannarella","year":"2025","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000515381","article-title":"European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis","volume":"14","author":"Muscogiuri","year":"2021","journal-title":"Obes. Facts"},{"key":"ref_54","unstructured":"Challa, H.J., Ameer, M.A., and Uppaluri, K.R. (2025, July 06). DASH Diet to Stop Hypertension, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482514\/."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12978-024-01758-5","article-title":"Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: A systematic review and network meta-analysis","volume":"21","author":"Stubnya","year":"2024","journal-title":"Reprod. Health"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1038\/s41591-025-03842-0","article-title":"Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: A randomized, crossover trial","volume":"31","author":"Dicken","year":"2025","journal-title":"Nat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","article-title":"Therapeutic Implications of Vitamin D and Calcium in Overweight Women with Polycystic Ovary Syndrome","volume":"28","author":"Pal","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/apm-20-2201","article-title":"Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: A meta-analysis study","volume":"10","author":"Zhao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_59","first-page":"511","article-title":"Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome","volume":"21","author":"Mohammadi","year":"2012","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_60","first-page":"212","article-title":"Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome","volume":"16","author":"Nadjarzadeh","year":"2015","journal-title":"J. Reprod. Infertil."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/jrms.JRMS_644_16","article-title":"Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome","volume":"22","author":"Khani","year":"2017","journal-title":"J. Res. Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/09513590.2021.1991910","article-title":"The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome","volume":"38","author":"Karamali","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/09513590.2022.2079629","article-title":"Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: A meta-analysis of randomized clinical trials","volume":"38","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s43032-021-00653-9","article-title":"Resveratrol and Markers of Polycystic Ovary Syndrome: A Systematic Review of Animal and Clinical Studies","volume":"29","author":"Rafraf","year":"2022","journal-title":"Reprod. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12020-023-03479-4","article-title":"Effects of resveratrol on polycystic ovarian syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"83","author":"Larik","year":"2024","journal-title":"Endocrine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s12602-018-9493-9","article-title":"The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"11","author":"Heshmati","year":"2019","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41430-019-0434-9","article-title":"Effect of probiotics and synbiotics on selected anthropometric and biochemical measures in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"74","author":"Hadi","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Martinez Guevara, D., Vidal Ca\u00f1as, S., Palacios, I., G\u00f3mez, A., Estrada, M., Gallego, J., and Liscano, Y. (2024). Effectiveness of Probiotics, Prebiotics, and Synbiotics in Managing Insulin Resistance and Hormonal Imbalance in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review of Randomized Clinical Trials. Nutrients, 16.","DOI":"10.3390\/nu16223916"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Razmpoosh, E., Sivanandy, M.S., and Ehrlich, A.M. (2025). The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010177"},{"key":"ref_70","first-page":"499","article-title":"Six-month randomized, placebo controlled trial of synbiotic supplementation in women with polycystic ovary syndrome undergoing lifestyle modifications","volume":"311","author":"Kubiak","year":"2025","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2006-2794","article-title":"Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome","volume":"92","author":"Vigorito","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Shele, G., Genkil, J., and Speelman, D. (2020). A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome. J. Funct. Morphol. Kinesiol., 5.","DOI":"10.3390\/jfmk5020035"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijgo.2012.01.027","article-title":"Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome","volume":"118","author":"Nidhi","year":"2012","journal-title":"Int. J. Gynaecol. Obs."},{"key":"ref_74","first-page":"323","article-title":"Regular Mindful Yoga Practice as a Method to Improve Androgen Levels in Women with Polycystic Ovary Syndrome: A Randomized, Controlled Trial","volume":"120","author":"Patel","year":"2020","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e19644","DOI":"10.1097\/MD.0000000000019644","article-title":"The effect of exercise as an intervention for women with polycystic ovary syndrome","volume":"99","author":"Ashe","year":"2020","journal-title":"Medicine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2024.01.018","article-title":"Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms","volume":"121","author":"Dokras","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"796594","DOI":"10.3389\/fpsyg.2022.796594","article-title":"The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: A meta-analysis","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Psychol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/oby.22980","article-title":"Weight Reduction Through a Cognitive Behavioral Therapy Lifestyle Intervention in PCOS: The Primary Outcome of a Randomized Controlled Trial","volume":"28","author":"Jiskoot","year":"2020","journal-title":"Obesity"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.rbmo.2021.05.008","article-title":"Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention","volume":"43","author":"Jiskoot","year":"2021","journal-title":"Reprod. Biomed. Online"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40337-022-00593-y","article-title":"Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): A randomized controlled trial","volume":"10","author":"Jiskoot","year":"2022","journal-title":"J. Eat. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e0233876","DOI":"10.1371\/journal.pone.0233876","article-title":"Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial","volume":"15","author":"Jiskoot","year":"2020","journal-title":"PLoS ONE"},{"key":"ref_83","first-page":"57","article-title":"Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: A randomized controlled trial","volume":"18","author":"Stefanaki","year":"2015","journal-title":"Stress Amst. Neth."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2004.05.098","article-title":"Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment","volume":"83","author":"Fleming","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/ejendo\/lvad098","article-title":"The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Melin","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_86","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.fertnstert.2025.04.009","article-title":"Effect of glucagon-like peptide 1 receptor agonist medications on weight loss in patients with and without polycystic ovary syndrome","volume":"124","author":"Gleason","year":"2025","journal-title":"Fertil. Steril."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Szczesnowicz, A., Szeliga, A., Niwczyk, O., Bala, G., and Meczekalski, B. (2023). Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185915"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e2231982","DOI":"10.1001\/jamanetworkopen.2022.31982","article-title":"Weight Loss Outcomes Associated with Semaglutide Treatment for Patients with Overweight or Obesity","volume":"5","author":"Ghusn","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity: The STEP 4 Randomized Clinical Trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity: The STEP 3 Randomized Clinical Trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: A randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Carmina, E., and Longo, R.A. (2023). Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185921"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590.2018.1505848","article-title":"The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls","volume":"35","author":"Kahal","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Marrioneaux","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12958-025-01447-3","article-title":"Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight\/obese women with polycystic ovary syndrome: A prospective, randomized, controlled, open-label clinical trial","volume":"23","author":"Chen","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: A pilot randomized study","volume":"179","author":"Salamun","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: A systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e250905","DOI":"10.1001\/jamahealthforum.2025.0905","article-title":"Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"},{"key":"ref_104","unstructured":"Kffcarenec (2025, August 22). Employer Health Benefits Survey. KFF. Available online: https:\/\/www.kff.org\/health-costs\/2024-employer-health-benefits-survey\/."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: An updated meta-analysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"Nissen","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/ijcp.12787","article-title":"Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: Systematic review and meta-analysis","volume":"70","author":"Graff","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Obesity in Pregnancy (2021). ACOG Practice Bulletin No. 230. American College of Obstetricians and Gynecologists. Obstet. Gynecol., 137, e128\u2013e144.","DOI":"10.1097\/AOG.0000000000004395"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Stefanaki, K., Karagiannakis, D.S., Peppa, M., Vryonidou, A., Kalantaridou, S., Goulis, D.G., Psaltopoulou, T., and Paschou, S.A. (2024). Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations. Nutrients, 16.","DOI":"10.3390\/nu16071049"},{"key":"ref_111","first-page":"164","article-title":"Naltrexone\/Bupropion ER (Contrave)","volume":"41","author":"Sherman","year":"2016","journal-title":"Pharm. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1210\/clinem\/dgab408","article-title":"Exenatide, Dapagliflozin, or Phentermine\/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome","volume":"106","author":"Chappell","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4158\/EP-2019-0609","article-title":"A Retrospective Study Examining Phentermine on Preconception Weight Loss and Pregnancy Outcomes","volume":"26","author":"Chang","year":"2020","journal-title":"Endocr. Pract."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Sancho","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11845-023-03488-2","article-title":"The impact of sleeve gastrectomy on polycystic ovarian syndrome: A single-center 1-year cohort study","volume":"193","author":"Alamdari","year":"2024","journal-title":"Ir. J. Med. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4240\/wjgs.v15.i11.2423","article-title":"Effect of laparoscopic sleeve gastrectomy on related variables of obesity complicated with polycystic ovary syndrome","volume":"15","author":"Wang","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u201cobesity-associated gonadal dysfunction\u201d in severely obese men and women and its resolution after bariatric surgery: A systematic review and meta-analysis","volume":"23","author":"Santacruz","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11695-021-05820-0","article-title":"The Effect of Gastric Sleeve Resection on Menstrual Pattern and Ovulation in Premenopausal Women with Classes III\u2013IV Obesity","volume":"32","author":"Tatarchuk","year":"2022","journal-title":"Obes. Surg."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"dgaa439","DOI":"10.1210\/clinem\/dgaa439","article-title":"Fertility and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome Following Bariatric Surgery","volume":"105","author":"Benito","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_122","first-page":"593","article-title":"Weight Regain following Bariatric Surgery and in vitro Fertilization Outcomes","volume":"17","author":"Igawa","year":"2024","journal-title":"Obes. Facts"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and Fertility Following Bariatric Surgery: A Systematic Review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/humupd\/dmn057","article-title":"Reproductive outcome after bariatric surgery: A critical review","volume":"15","author":"Guelinckx","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/obr.12927","article-title":"Pregnancy after bariatric surgery: Consensus recommendations for periconception, antenatal and postnatal care","volume":"20","author":"Shawe","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamasurg.2016.3621","article-title":"Bariatric Surgery in Women of Childbearing Age, Timing Between an Operation and Birth, and Associated Perinatal Complications","volume":"152","author":"Parent","year":"2017","journal-title":"JAMA Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/jc.2018-00750","article-title":"Vitamin D Deficiency Is Associated with Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility","volume":"104","author":"Butts","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12958-025-01415-x","article-title":"A multidisciplinary approach to weight management and reproductive care: A retrospective cohort study on weight loss through personalized and patient-centered care","volume":"23","author":"Schon","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e70051","DOI":"10.1002\/osp4.70051","article-title":"Testing a Personalized Behavioral Weight Loss Approach Using Multifactor Prescriptions and Self-Experimentation: 12-Week mHealth Pilot Randomized Controlled Trial Results","volume":"11","author":"Martinez","year":"2025","journal-title":"Obes. Sci. Pract."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/11\/518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:48:57Z","timestamp":1762192137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/11\/518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":129,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jpm15110518"],"URL":"https:\/\/doi.org\/10.3390\/jpm15110518","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}